Alx Oncology Holdings Inc [ALXO] stock is trading at $1.51, down -3.21%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ALXO shares have gain 4.86% over the last week, with a monthly amount drifted -29.44%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Alx Oncology Holdings Inc [NASDAQ: ALXO] stock has seen the most recent analyst activity on March 08, 2024, when Stifel downgraded its rating to a Hold and also boosted its price target to $14 from $10. Previously, Jefferies upgraded its rating to Buy on December 08, 2023, and elevated its price target to $18. On December 22, 2021, downgrade downgraded it’s rating to Hold and revised its price target to $25 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $106 on September 30, 2021. In a note dated April 06, 2021, UBS initiated an Buy rating.
Alx Oncology Holdings Inc [ALXO] stock has fluctuated between $1.42 and $17.83 over the past year. Currently, Wall Street analysts expect the stock to reach $24.5 within the next 12 months. Alx Oncology Holdings Inc [NASDAQ: ALXO] shares were valued at $1.51 at the most recent close of the market. An investor can expect a potential return of 1522.52% based on the average ALXO price forecast.
Analyzing the ALXO fundamentals
Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -72.82%, Pretax Profit Margin comes in at -69.13%, and Net Profit Margin reading is -69.13%. To continue investigating profitability, this company’s Return on Assets is posted at -0.8, Equity is -9.47 and Total Capital is -1.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4700 points at the first support level, and at 1.4300 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5600, and for the 2nd resistance point, it is at 1.6100.
Ratios To Look Out For
For context, Alx Oncology Holdings Inc’s Current Ratio is 4.39. Further, the Quick Ratio stands at 4.39, while the Cash Ratio is 0.4.
Transactions by insiders
Recent insider trading involved Pinto Shelly, SVP, FINANCE AND CAO, that happened on Aug 14 ’24 when 564.0 shares were sold. CHIEF MEDICAL OFFICER, Randolph Sophia completed a deal on Aug 14 ’24 to sell 1365.0 shares. Meanwhile, PRESIDENT & CSO Pons Jaume sold 1937.0 shares on Aug 14 ’24.
